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Executive Summary
The first national survey of Australian wild caught abalone was conducted between September 2012 and December 2013. The aim of the survey was to determine the presence of paralytic shellfish toxins (PSTs), amnesic shellfish toxins (ASTs) and diarrhetic shellfish toxins (DSTs) in wild caught abalone at levels above the current Codex marine biotoxin limits during the 2013 fishing season. Abalone (n=190) were collected from 68 abalone-fishing blocks for which the combined annual harvest accounts for 80% of Australian production. The foot and viscera tissues of each sample were separately analysed for PSTs, ASTs and DSTs. No samples (abalone foot or viscera) contained toxins at levels exceeding the regulatory limits stipulated in the Australia New Zealand Food Standards Code. The resulting prevalence estimate suggests that less than 1.6% of the commercially caught wild abalone population in Australia were contaminated with marine biotoxins at levels above the regulatory limit during the survey period. ASTs were detected in the foot tissue of four abalone samples and the viscera tissue of three abalone samples at very low (trace) levels; this represents the first reported detection of domoic acid in Australian abalone. PSTs were also detected at very low levels in 17 samples of abalone foot tissue and 6 samples of abalone viscera. Concurrent seawater samples were collected and potentially toxic phytoplankton were enumerated. The association between the low levels of ASTs and PSTs detected in abalone and the presence of potential-toxin producing phytoplankton in seawater samples was weak. DSTs were not detected in any abalone despite the detection of very low levels of DST-producing phytoplankton in a small number of seawater samples (9 of 77 samples). The results of this survey should be useful for public health risk assessments and provide additional evidence that the prevalence of marine biotoxins in Australian wild caught abalone is very low.
Introduction
Certain species of dinoflagellates and diatoms are documented to produce a variety of chemical compounds frequently referred to as 'marine biotoxins'. According to recent toxin classification systems, there are 8 different groups of marine biotoxins, with each toxin group comprising multiple toxin analogues (21) . When blooms of these toxin-producing dinoflagellates or diatoms occur, bivalve shellfish can accumulate high levels of toxins in their gut and tissues through the act of filter feeding. Cases of human illness have been widely documented in relation to the consumption of bivalve shellfish that contain high levels of such toxins (10-12, 21, 23, 33) . Thus, in Australia four of the most serious toxin groups are regulated in bivalve shellfish, namely: paralytic shellfish toxins (PSTs), neurotoxic shellfish toxins (NSTs), amnesic shellfish toxins (ASTs) and diarrhetic shellfish toxins (DSTs).
Marine biotoxins have also been detected in a range of non-bivalve marine organisms, generally carnivorous species such as whelks, lobsters and crabs (2, 8, 19, 24, 25, 31) . Some species of abalone, which are herbivores that graze on macro algae, have also been documented to accumulate PSTs and DSTs. Specifically, PSTs have been reported to occur in: Haliotis tuberculata from Spain; Haliotis midae from South Africa; Haliotis rubra and Haliotis laevigata from Australia; and Haliotis iris from New Zealand (3, 5, 9, 17, 26, 28, 30) . Additionally, DSTs have been detected in abalone from Spain, New Zealand and Korea (14, 16, 19) . The accumulation pathway for abalone is somewhat contentious, with various modes of contamination proposed involving different intermediaries such as toxin-producing phytoplankton, bacteria and macroalgae (3, 4, 13, 20, 26) . Recent studies in Australia and New Zealand have demonstrated a link between toxin-producing phytoplankton and the presence of marine biotoxins in abalone, particularly in abalone viscera (16, 17, 28) ; there is no evidence that other toxin sources play a role in the contamination of abalone in Australia at this time.
The identification of marine biotoxins in abalone raised international concerns regarding the safety of abalone for human consumption. Consistent with these concerns, the Codex Committee on Fish and Fishery Products progressed the development of a new standard on abalone. This Standard was finalised in 2013 and requires that countries undertake risk assessments of marine biotoxins in abalone to determine if a risk exists in the geographical areas under its control, and if so to ensure that abalone comply with the bivalve shellfish maximum regulatory limits for biotoxins (7) . Additionally, several countries (e.g. South Africa, the European Union and China) now regulate for marine biotoxins in abalone in addition to the traditionally regulated bivalve molluscan shellfish.
Australia has a significant commercial wild capture abalone industry, comprising the world's largest fishery with catch totalling around 4400 tonnes in 2012, representing approximately 25% of annual global harvest (32) . Given the significance of the wild capture abalone industry in Australia, in 2010 a preliminary risk assessment was completed. The result of the semi-quantitative assessment suggested that the probability of EU and Chinese consumers of canned Australian abalone becoming ill from PSP is 'Extremely Low' (27) . However, the authors noted many data gaps and recommended that these be addressed to improve the reliability of the risk estimates. One of the major data gaps identified was a lack of toxin data for wild caught Australian abalone from major fishing zones: at the time of the 2010 risk assessment, only 52 abalone samples had been collected between 2002 and 2004 and analysed for the major regulated toxin groups.
The large data gaps identified in the initial risk assessment, together with the new Codex requirements, prompted major abalone stakeholders (regulatory and industry) in Australia to instigate further data collection. Thus, the first national survey of marine biotoxins in wild caught abalone in Australia was conducted to provide objective evidence to support food safety risk assessment. The main aim of the present study was to determine the presence of PSTs, ASTs and DSTs in wild caught abalone at levels above the current Codex marine biotoxin limits during the 2013 fishing season.
Methods

Design of the study
Wild caught abalone are primarily located around the southern coastline of Australia and there are four species that are harvested commercially: H. rubra (blacklip abalone), H. laevigata (greenlip abalone), Haliotis roei (roe's abalone) and Haliotis conicopora. The commercial catch of abalone is highest in Tasmania, followed by Victoria and South Australia, with small amounts harvested from Western Australia and New South Wales. Each abalone fishery management authority divides the State's abalone fishing regions into small areas for quota management related activities, and these are often further divided into blocks, which are further divided into sub-blocks 1 .
We aimed to collect a total of 227 abalone samples, which would provide a probability of 95% of detecting at least one sample that contained marine biotoxins above the regulatory limit if at least 0.8% of the abalone population violated the maximum permissible level during the survey period. Samples were collected from 21 September 2012 to 1 December 2013 from all major abalone-fishing zones (20 of the 25 zones) in each abalone-producing State. In total, samples were to be collected from 68 abalone-fishing blocks whose combined production accounted for 80% of Australian wild caught abalone production.
The overall sample size was allocated proportionally to abalone harvesting blocks based on production volumes (based on average harvest per annum between 2006 and 2010). Therefore, generally higher numbers of samples were collected from the most productive fishing blocks. The allocation of sampling was undertaken as follows: 1. Abalone samples were proportionally allocated to each State based on total volume caught in that State. 2. For each State, samples were allocated to zones based on the contribution to the total wild caught abalone production volume. 3. For each abalone species within a zone, samples were proportionally allocated based on the volume of each species harvested within that zone. 4. For each zone and species, samples were then randomly allocated to blocks using sampling with replacement and each block was given a probability of selection that was equal to the blocks' catch contribution to the zones overall catch volume. The planned sample allocation is shown in Table 4 . To avoid bias through choosing the time of sampling, sampling times were randomly selected for each block on a monthly basis. The study design ensured that the abalone tested during this study reflected the full range of commercially caught wild abalone, including differences in species, size and age across Australia.
Sample collection
State fishery managers and industry divers collected the abalone samples during the course of stock assessment or commercial diving activities. 24 hours of collection, or were immediately frozen to approximately -20°C and dispatched to the processing laboratory within several weeks.
To estimate the abundance of potentially toxic phytoplankton, seawater samples were collected alongside abalone samples. Seawater samples were 600 mL grab samples collected directly adjacent to each abalone sample. Each water sample was immediately preserved with acidified Lugols iodine solution and generally dispatched to the SARDI processing laboratory within 24 hours, or in some cases within several weeks. Where multiple seawater samples were collected from the same abalone block at the same time, only one seawater sample (randomly selected from those collected) was analysed. The location (GPS coordinates), seawater depth and temperature for each sample were recorded.
Abalone sample preparation
Upon arrival at the SARDI processing laboratory, the shell of each abalone was gently scrubbed and the abalone were rinsed in running freshwater to remove sand, seaweed and foreign objects and drained for 5 min. The shell width, length and weight, and weight of the foot and viscera tissues (after shucking), were recorded. The abalone were then shucked and the viscera dissected from the muscular foot tissue using a scalpel. The viscera samples comprised all tissues except the foot, the foot samples included the fringe; viscera and foot tissues were analysed separately. Samples that could not be processed immediately following collection were stored at 4°C for a maximum of 2 days. Abalone viscera and foot tissues were then homogenised separately using a hand held blender for at least one minute or until a fine homogenate was achieved.
To enable the collection and analysis of a larger number of abalone samples within the resources allocated for the project, 3 abalone samples were pooled for analytical purposes. The pooling of samples was undertaken by combining 30 g of homogenate from each of 3 abalone foot samples to provide one 90 g sample for testing purposes. Similarly, 30 g of homogenate from each of 3 viscera samples were pooled. For smaller animals, 15 g of homogenate from each of 3 abalone were pooled. This approach was followed for 189 of the 190 samples collected, resulting in 63-pooled samples. The viscera and foot tissues of the 1 remaining sample were analysed separately. This gave a total of 64 foot and 64 viscera samples for analysis. Individual abalone used to make up a pooled sample were generally of the same approximate size and species. Abalone homogenates were frozen to at least -20°C ± 2°C prior to dispatch and subsequent chemical testing at Advanced Analytical Australia Ltd. Pty.
Abalone analysis
Abalone samples were analysed for three major groups of marine biotoxins: PSTs, DSTs and ASTs. The National Association of Testing Authorities (NATA) accredited the analytical methods used for this study to ISO 17025. Abalone were not analysed for the presence of NSTs due to the lack of an appropriate analytical method for these toxins in Australia at the time of the study.
Paralytic shellfish toxins
Extraction, oxidation and quantitation of abalone (foot and viscera analysed separately), were undertaken as described in the AOAC Official Method 2005.06
Paralytic Shellfish Poisoning Toxins in Shellfish as known as the Lawrence method (22).
The method has screening and confirmation steps. HPLC analysis was undertaken on a Varian 920-LC liquid chromatograph with a built in time programmable fluorescence detector. Chromatographic separation was achieved with an Agilent C18 reversedphase column (150 x 4.6 mm, 5 µm particle size) employing gradient elution at a flow rate of 2 mL min -1
. All reagents were comparable to those detailed in the AOAC method protocol 2005.06. All samples were analysed by LC-FLD following periodate oxidation of the pH adjusted solid phase extraction (SPE) extract. This portion of the Lawrence method is routinely used by Advanced Analytical Ltd. Pty. as a screening test for the analysis of PSTs in shellfish samples. The screen test overestimates the total toxin level and consequently sample toxicity because several PSTs give multiple co-eluting oxidation products and it is assumed that the entire peak is due to the most potent congener (15) .
Certified PST reference material was obtained from the Institute of Marine Biosciences, National Reference Council Canada (NRCC, Halifax, Nova Scotia, Canada) and included: saxitoxin (STX), neosaxitoxin (NEO), gonyautoxin 1,4 (GTX1,4), gonyautoxin 2,3 (GTX2,3), gonyautoxin 5 (GTX5, B1), decarbamoylsaxitoxin (dcSTX), decarbamoylneosaxitoxin (dcNEO), decarbamoylgonyautoxin 2,3 (dcGTX2,3) and Nsulfocarbamoylgonyautoxin 2,3 (C1,2). To account for the variable toxicity of the PST congeners quantified, the value for each congener was adjusted using the current accepted toxicity equivalence factors and then the values for each congener were summed to provide a measure of the total toxicity of the sample (22, 29).
Diarrhetic and amnesic shellfish toxins
The method used for DSTs and ASTs was a multi-toxin liquid chromatography tandem mass spectrometer (LC/MS/MS) detection method which detects a range of toxins including: (1) ASTs -domoic acid (DA) and epi-domoic acid (e-DA); (2) DSTs -okadaic acid (OA) and dinophysistoxins (DTX); and (3) other lipophilic toxins including, yessotoxins (YTX), azaspiracids (AZA), spirolide (SPX), gymnodimine (GYM), pectenotoxins (PTX) and cylindrospermopsin (CYN). Extraction and quantitation were undertaken as previously described (34). Briefly, a methanol extract of the homogenized abalone tissue is prepared. An additional hydrolysis step is performed prior to analysis to remove the fatty acid chains bound to OA, DTX1 and DTX2 by base hydrolysis of the methanolic extract. The hydrolysed extracts are further neutralized with acid. The analytes extracted in the methanol extract, and following the hydrolysis step, are then analysed by LC/MS/MS, thus the esters of OA and DTX are included in the analysis. LC/MS/MS analysis was undertaken on an Agilent 1290 UPLC coupled with an ABSciex Qtrap 5500 instrument. All reagents were similar to those detailed previously (34). The certified reference standards were purchased from NRCC and the mixed working standard solutions contain DA, OA, DTX1, DTX2, YTX, PTX2, SPX1, GYM and AZAs1, 2, and 3.
Limits of reporting
The limit of reporting (LoR) for each method (PSTs, ASTs, DSTs) was 0.025 mg kg -1 . The sub-sampling and pooling approach (i.e. 30g of tissue from each of 3 abalone was pooled for analysis) would enable levels three fold higher than the LoR (i.e. 0.075 mg kg 
Seawater analysis
Seawater samples were analysed using a microscopy-based method for the presence of potential toxin-producing phytoplankton at Microalgal Services Ltd. Table 1 shows the phytoplankton species that were targeted in the analysis and the recommended associated alert level that is used to initiate flesh testing in bivalve shellfish growing areas in Australia (1). Where doubts existed over identification of certain species, they were treated as potentially toxic species. Phytoplankton cells in Lugol's preserved seawater samples were concentrated by gravity assisted membrane filtration (using a 5 filter) prior to counting. Cells were counted in a Sedgewick-Rafter counting cell using a Zeiss Axiolab microscope equipped with phase contrast optics. Concentrations were reported as cells L -1 . AST 50000
Pseudo-nitzschia delicatissima group AST 500000
Data analysis
The R software (R Core Development Team) was used to randomly select abalone blocks to sample (weighted for production) and to generate the prevalence estimates and associated confidence intervals. Microsoft Excel was used to prepare summary measures and graphs from the raw analytical results.
Production data between 2006 and 2010 were used to develop the sampling plan. To assess whether the actual sampling undertaken reflected production levels, the proportion of samples taken from each area (State, zone and block) and the proportion of production in the same area were tested for significant difference using a chi-squared test for equal proportions. The same approach was used to compare planned and actual sample numbers by calendar month.
Estimates of prevalence of abalone with toxin levels above the regulatory limit were calculated together with an approximate 95% confidence interval. Results and Discussion
Abalone results
We aimed to collect 227 abalone samples, however only 190 samples were able to be collected for a variety of reasons; primarily poor weather conditions preventing diving, and a lack of abalone fishing and stock management activities in some blocks during the course of the study. As noted previously, abalone samples were pooled for analytical purposes, this resulted in 64 abalone foot samples and 64 abalone viscera samples, which were analysed for PSTs, DSTs and ASTs. Summary results for each toxin group are presented in Table 2 .
Paralytic shellfish toxins
The highest level of PSTs detected in a pooled sample of abalone foot tissue was 0.17 mg STX eq kg -1 and the highest level in viscera was 0.10 mg STX eq kg -1
. When considering PST levels in the individual abalone from which these pooled samples were derived, the maximum amounts that could have been present in the individual abalone foot and viscera tissue were 0.51 and 0.30 mg STX eq kg -1 respectively, if 2 of the 3 abalone in the pooled sample contained no toxins. Thus, no individual samples collected during the survey (n=190) were above the regulatory limit for PSTs (0.8 mg STX eq kg -1 ) .
Low levels of PST were detected in 23 of the 64 pooled samples analysed, of which 17 comprised foot and 6 viscera tissue. A recent study undertaken in Australia has demonstrated a link between toxin-producing phytoplankton (Alexandrium tamarense and Gymnodinium catenatum) and the presence of PSTs in abalone (28) . The authors also showed that the elimination rate of PSTs from abalone foot tissue is less than that for abalone viscera tissue, and others have also suggested that the foot tissue has a higher capacity to retain toxins than other parts of the body (26, 28) . The retention of PSTs in abalone foot tissue for extended periods may provide some explanation for the higher number of low-level positives in the foot than the viscera tissue during this survey.
Amnesic shellfish toxins
The highest level of ASTs detected in a pooled sample of abalone foot tissue was 0.14 mg STX eq kg -1 and the highest level in the viscera was 0.77 mg STX eq kg -1
. When considering AST levels in the individual abalone from which these pooled samples were derived, the maximum amounts that could have been present in the individual abalone foot and viscera tissue were 0.42 and 2.31 mg STX eq kg -1 respectively, if 2 of the 3 abalone in the pooled sample contained no toxins. Thus, no individual samples collected during the survey (n=190) were above the regulatory limit for ASTs (20 mg kg -1 ). Low levels of AST were detected in 7 of the 64 pooled samples analysed, of which 4 comprised foot and 3 viscera tissue. This is the first reported occurrence of ASTs in abalone from Australia, although trace levels of ASTs have been previously reported in New Zealand abalone (18).
Diarrhetic shellfish toxins
No DSTs, including OA, DTXs and their esters, were detected in any sample. DSTs have not been previously detected in Australian abalone. DSTs have been detected at low levels in abalone from New Zealand, Korea and Spain (14, 16, 19) .
The analytical test (LC/MS/MS) used for DSTs also includes several other lipophilic toxins. AZA's, PTX's, SPX's, GYM, and CYN were also not detected in any sample. Low levels of YTX were detected in 23 of the 64 pooled samples, of which 21 samples were viscera tissue. The highest level detected was 0.14 mg kg -1 in a pooled viscera sample. YTXs have also been reported to be present in abalone from Korea and New Zealand (16, 19) . YTXs are not regulated in Australia. 
Prevalence estimate
In summary, no samples (abalone foot or viscera) contained PSTs, AST's or DST's at levels exceeding the regulatory limits (for bivalve shellfish) stipulated in the Australia New Zealand Food Standards Code. This suggests that less than 1.6% (95% CI of 0% -3.3%) of the commercially caught wild abalone population in Australia were contaminated with marine biotoxins at levels above the regulatory limit during the survey period.
Phytoplankton results
Seawater samples (n=187) were collected concurrently with abalone sampled (n=190) during the survey. Three of the possible 190 seawater samples were not provided by samplers or were not suitable for analysis. When multiple seawater samples were collected from the same block at the same time, only one of the samples was analysed (to conserve project resources). Therefore, a total of 77 samples were analysed for the presence of potentially toxic phytoplankton (detailed in Table 1 ). Phytoplankton were not generally speciated beyond genus level. Table 3 provides an overview of the phytoplankton results. Six of the 77 samples analysed contained potential PST producing plankton; plankton in one sample exceeded the Australian Shellfish Quality Assurance Program trigger level for flesh testing of bivalves. The sample was coincidentally collected during a PST-producing bloom of Alexandrium that impacted the east coast of Tasmania in 2012 (6) . The seawater sample was collected in October 2012 and was reported to contain 1200 cells L -1 of Alexandrium tamarense. The corresponding abalone sample (collected from the same location at the same time) was found to contain low levels of PST in both the foot and viscera tissues. An additional seawater sample was also collected from the eastern zone of Tasmania in December 2012 and was reported to contain 20 cells L -1 of Alexandrium catenella: the corresponding abalone contained 0.079 mg STX eq kg -1 in the foot tissue (viscera tissue <LoR). These positive samples may also have been related to the 2012 PST-producing bloom of Alexandrium (6) . Of the remaining four seawater samples in which PST producing plankton were detected, abalone collected concurrently did not have detectable levels of PST.
Potential AST producing plankton were detected in 24 seawater samples, however only one sample contained Pseudo-nitzschia group cells (127,600 cells L -1 ) at levels exceeding the flesh testing triggers noted in Table 1 . Four abalone were collected from the same fishing block (Victoria, eastern zone) on the same day as this seawater sample and ASTs were not detected in any of the foot or viscera tissues. Seven abalone samples (3 viscera and 4 foot samples) were found to contain low levels of ASTs (Section 3.1.2), however only 2 of the corresponding seawater samples contained Pseudo-nitzschia group cells at 1400 cells L -1
; well below the flesh testing trigger.
Potential DST producing plankton were detected in 9 samples, however levels were extremely low (<60 cells L -1 ). No DST was detected in any abalone samples, including those collected concurrently with the seawater samples reported to have low levels of potential DST producers present.
With the exception of samples coincidentally collected during the 2012 Alexandrium tamarense event in 2012, the association between the detection of PSTs, ASTs and DSTs in abalone and the presence of potential-toxin producing plankton in concurrently collected seawater samples was weak. The lack of association could be attributed to many factors, including:
1) The retention of very low levels of PSTs and ASTs in abalone tissues following previous algal bloom events; 2) Phytoplankton 'patchiness' resulting in seawater samples that did not contain algal cells; 3) The levels of PST and AST detected in abalone were very low and may have resulted from the presence of very low levels of phytoplankton cells in the seawater that were below the LoR of the enumeration method.
Spatial and temporal sample distribution
Given the reduced number of samples collected (n=190), an assessment was made as to whether the abalone samples collected were still proportional to the volume of abalone harvested from each State, zone and block. The proportion of samples collected from each State (5 States) and zone (25 zones) was not significantly different from the proportion of production in each area (P=0.82 for States and P=0.98 for the zones). Table 4 shows the proportion of wild caught abalone commercially harvested from each State (between 2006 and 2010), the number of samples allocated, and the number of samples actually collected in the survey.
At a block level, many blocks in which commercial abalone harvest is extremely low were not sampled, as they were not selected using the random weighted sampling approach. We also found that 11 of the 68 blocks from which samples were collected were over-sampled, with the difference between the proportion of commercial abalone harvested and the proportion of samples collected from these blocks ranging from 8.5% -95%. The differences noted for 8 of the 11 blocks were statistically significant (P<0.05). To avoid temporal sampling bias, sample collection times were randomly allocated for each fishing block on a monthly basis throughout the year. However, the proposed sample collection times were not always adhered to, as industry and fishery stock assessment staff conducted sampling at times that coincided with their everyday work. We found a significant difference between the proportion of samples collected per month and the proportion of abalone commercially harvested per month (P<0.03), which indicates that there was a temporal sampling bias in the survey.
The number of abalone samples collected per month is shown in Figure 1 . It is notable that few samples were collected during the winter months of June, July and August; the majority of samples were collected between the months of October and March. Harvesting of wild caught abalone occurs year round in Australia, however fishing is weather and market dependent: higher volumes of abalone are harvested over the summer months from October through to April, when the weather conditions are mild and to fulfil the demands of supplying abalone for the Chinese New Year (January/February). Harvest volumes are lower during the months of June, July and August (data not shown). Thus, while there was a temporal sampling bias observed (compared to the initial allocation), the pattern of sampling for the survey was broadly consistent with industry harvesting practices and hence provides a better representation of consumer exposure. Nonetheless, both surveys undertaken to date indicate that the prevalence of marine biotoxins at levels exceeding the regulatory limit in Australian wild caught abalone is very low. This is consistent with available epidemiological information in Australia; no cases or outbreaks of illness have been suspected or confirmed in relation to biotoxins in abalone. The results of this survey should be useful for food safety risk assessments, particularly to support acute exposure assessment for which data on the concentration and proportion of the abalone population containing critical levels of toxins is required.
